Delic Holdings Corp

Tower One Wireless Corp, founded in 2015 and based in Vancouver, BC, is a public company dedicated to owning and operating high-quality cellular network infrastructure sites primarily in South America and North America. The company focuses on constructing towers in areas with limited or no cellular coverage, facilitating shared usage among multiple operators to mitigate competitive risks. With a Build-to-Suit strategy for Mobile Network Operators, Tower One Wireless ensures long-term site leases are secured before construction begins, generating attractive returns. The company is managed by seasoned industry experts and is currently expanding its 4G LTE and 5G infrastructure across Canada, Colombia, Mexico, Ecuador, and the United States. Generated from the website

Algernon Pharmaceuticals Inc., based in Vancouver, BC, is a clinical-stage Canadian drug development and repurposing company focused on addressing unmet global medical needs through innovative therapeutic applications. The company employs a cost-effective drug repurposing model, leveraging existing compounds with established safety profiles to expedite the discovery of new treatments for various diseases. Algernon's current pipeline includes NP251 (Repirinast), originally developed for asthma, now being repurposed for chronic kidney disease, and AP188 (NN-Dimethyltryptamine), which is being investigated as a potential treatment for stroke and traumatic brain injury. The company is also advancing its research through its subsidiary, Algernon NeuroScience, and is actively conducting clinical trials to support its drug development programs. Generated from the website

Core One Labs Inc. is a Vancouver-based life sciences company dedicated to advancing psychedelics through innovative research and development. With a focus on producing cost-effective psychedelic compounds, including psilocybin, the company strives to become a vertically integrated supplier serving both individuals and corporations. Operating through three distinct business units—psychedelic compound production, drug development, and medical clinics—Core One Labs facilitates patient access to legal psychedelic treatments while developing a pipeline of patent-pending compounds aimed at addressing mental health and neurological disorders. Generated from the website